SGLT2 inhibitors and GLP-1 receptor agonists exhibit renoprotective effects in patients with CKD with and without diabetes.

These drugs are collectively known as GLP-1 agonists because they mimic the body’s natural hormone GLP-1, which regulates ...

Grapefruit can interact with many medications, potentially affecting the way they work or increasing side effects. Some of ...

After years in shortage, weight loss and diabetes drugs Ozempic and Wegovy are now considered to be “available” by the Food ...

In interviews with Reuters, eight U.S. obesity specialists at universities and large health systems described a different ...

Telehealth company Hims & Hers said late Monday in an earnings update that it plans to launch a generic version of Novo ...

It is a sign that Novo Nordisk’s efforts to ramp up the supply of those drugs are starting to pay off, as demand continues to ...

Doctors are currently using stem cells to treat a variety of medical conditions — and that list could soon become even larger ...

The diabetes and weight loss medications Ozempic and Wegovy are now considered to be available after more than two years of ...

Eli Lilly' s blockbuster weight loss drug Zepbound and diabetes treatment Mounjaro posted weaker-than-expected sales for the ...

and highly personalised treatment alternative. With continued research and refinement, the DT intervention may become a ...

Our list of online ... brand-name semaglutide medications. The primary difference is the dosing and FDA approval. Wegovy is ...